Form 4: Inovio Pharmaceuticals Director Jay Shepard Reports Stock Transactions
SEC Form 4 Filing
Director Jay Shepard reports the vesting and disposal of restricted stock units into common stock on May 21, 2025.
Summary
- On May 21, 2025, Jay Shepard, a director of Inovio Pharmaceuticals, reported transactions involving the company's stock.
- Shepard acquired 2,167 shares of common stock through the vesting of restricted stock units.
- Simultaneously, Shepard disposed of 2,167 shares.
- Following these transactions, Shepard directly owns 9,209 shares of Inovio Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by a company director, and doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine transaction by a company director.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of earliest transaction, vesting of restricted stock units, and date of report. |
Keywords
Form 4, INO, Inovio Pharmaceuticals, Director, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Jay Shepard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.